Exelixis Inc. diskutieren
Exelixis Inc.
WKN: 936718 / Symbol: EXEL / Name: Exelixis / Aktie / Biotechnologie & medizinische Forschung / Mid Cap /
37,03 €
-1,65 %
Exelixis (NASDAQ:EXEL) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ratings data for EXEL provided by MarketBeat
Exelixis (NASDAQ:EXEL) had its price target raised by analysts at HC Wainwright from $49.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for EXEL provided by MarketBeat
Exelixis (NASDAQ:EXEL) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $52.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat
Exelixis (NASDAQ:EXEL) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for EXEL provided by MarketBeat
Neueste Beiträge
Bank_of_America_Co_ in Quanta Services diskutieren